Endoscopic submucosal tunnel dissection (ESTD) was first described in humans in 2010 by Inoue et al. for conducting peroral endoscopic myotomy 1. Recently, it was proposed in esophageal and gastric ...
Compared to minimally invasive surgery, endoscopic submucosal dissection (ESD) represents an advanced, less-invasive endoscopic treatment for early gastrointestinal cancer. ESD has significant ...
Safety and efficacy of combining genotype-guided irinotecan (Iri) with 5FU, leucovorin (LV), oxaliplatin (Ox), and docetaxel (Tax) (gFOLFOXIRITAX): The I-FLOAT phase 1 dose-escalation study for ...
For patients with large benign colonic lesions, endoscopic submucosal dissection (ESD) is associated with reduced recurrence at six months compared with endoscopic mucosal resection (EMR), according ...
Current evidence shows an inter-country inconsistency in the effect of lesion size on the technical difficulty of gastric endoscopic submucosal dissection (ESD). We aimed to evaluate the specific ...
FUJIFILM Healthcare Europe GmbH is pleased to announce the launch of EndoGel, a training model designed for performing Endoscopic Submucosal Dissection (ESD) and Peroral Endoscopic Myotomy (POEM) ...
Nivolumab (NIVO) + chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 4 year (yr) ...
Jawaid S, Yang D, Draganov PV. " Esophageal POEM: The New Standard of Care. " Transl Gastroenterol Hepatol.; Jawaid S, Yang D, Draganov PV. " Endoscopic submucosal dissection of a large squamous cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results